Amman-Mubasher: The Jordanian Pharmaceutical Manufacturing (JPM) posted a 46.7% surge in its losses for the first quarter of 2015, reaching JOD 2.42 million ($3.41 million) from JOD 1.65 million ($2.33 million) in Q1-14, according to a filing to Amman Stock Exchange.

The company said its losses skyrocketed 233.3% to JOD 5.9 million in 2014, compared to JOD 1.77 million in 2013.

JPM’s capital amounts to JOD 40 million, distributed on 40 million shares at JOD 1 par value each.